Short-term Function and Pain After Treatment for Dupuytren's Disease

• Status: Unknown status
• Trial end date: 2017-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate short-term pain and function associated with percutaneous needle aponeurotomy (PNA) and injections of the enzyme collagenase clostridium histolyticum in patients with Dupuytren's disease. Scores on outcome measures will be compared between groups to determine whether treatments differ in terms of hand function and pain during the early post-treatment period.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sunnybrook Health Sciences Centre

Criteria

Inclusion Criteria:

• Adult

• Dupuytren's disease diagnosis

• Consented to either percutaneous needle aponeurotomy or Xiaflex injection (patient choice)

• Able to read/write/speak English

• Must have an email address

Exclusion Criteria:

• Previous treatment for Dupuytren's disease

• Type 2 Diabetes Mellitus

• Pre-existing hand condition, previous hand surgery or trauma